Boston Scientific Total Current Assets decreased by 1.3% to $8.68B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.4%, from $7.34B to $8.68B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 5.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.76B | $6.23B | $6.32B | $5.07B | $5.08B | $5.14B | $5.76B | $5.70B | $5.89B | $6.50B | $6.51B | $8.19B | $8.99B | $8.76B | $6.92B | $7.34B | $7.12B | $8.04B | $8.79B | $8.68B |
| QoQ Change | — | -7.8% | +1.4% | -19.8% | +0.4% | +1.2% | +12.0% | -1.0% | +3.2% | +10.5% | +0.2% | +25.7% | +9.8% | -2.6% | -21.0% | +6.0% | -2.9% | +12.8% | +9.4% | -1.3% |
| YoY Change | — | — | — | — | -24.8% | -17.4% | -8.8% | +12.6% | +15.8% | +26.4% | +13.1% | +43.5% | +52.8% | +34.7% | +6.2% | -10.4% | -20.8% | -8.3% | +27.1% | +18.4% |